Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studies
Myung‐Ju Ahn, Nobuyuki Yamamoto, Takayuki Asato, Pingkuan Zhang et al.
Journal
Lung Cancer
Topics
Lung Cancer Treatments and Mutations
article
Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studies
Myung‐Ju Ahn, Nobuyuki Yamamoto, Takayuki Asato, Pingkuan Zhang, Tony S.K. Mok, Edward S. Kim, Kentarou Kudou, Makoto Nishio, Tatsuya Yoshida, Sylvie Vincent, Hui Yang, Xin Tong
article en
Abstract
No abstract available for this paper.
Publication Tag
Lung CancerVol. 209
Institutions
City Of Hope National Medical Center (US), Chinese University of Hong Kong (HK), Wakayama Medical University (JP), Samsung Medical Center (KR), National Cancer Centre Japan (JP), National Cancer Center (US), The Cancer Institute Hospital (JP), Takeda (United States) (US), Japanese Foundation For Cancer Research (JP), Takeda (Japan) (JP)